Shu-hui Liu PhD

Dr. Shu-Hui Liu is the Director of the Tumor Biology Department at Cancer Immunology Discovery Unit at Pfizer. Dr. Liu earned her Ph.D. degree from National Tsing-Hua University and Academia Sinica in Taiwan, and conducted her postdoctoral research at University of California, San Francisco, USA. She was trained as a Cell Biologist and has over 17 years of biopharmaceutical industry experience (with the last ~10 years at Pfizer) in the target and drug discovery areas focusing on large molecule therapeutics for oncology indications. Her group at Pfizer is currently working on several clinical and preclinical oncology projects including naked antibodies, antibody-drug-conjugates, bi-specific molecules and CART cell therapeutics spanning the broad immune-oncology field. She is author/co-author of ~30 publications and is the inventor/co-inventor of numerous oncology target/Ab/technology patents.